×
For best experience we recommend to activate Javascript in your browser.
Recombinant RABV G (Mazorelvimab Biosimilar) antibody
The Humanized Monoclonal anti-RABV G (Mazorelvimab Biosimilar) antibody (ABIN7488403) specifically detects RABV G (Mazorelvimab Biosimilar) in ELISA and WB.
The antibody is reactive with Lyssavirus rabies (RABV) samples.
Catalog No. ABIN7488403
$579.16
Plus shipping costs $50.00
1 mg ABIN7470514
100 μg ABIN7488403
1 mg ABIN7470514
100 μg ABIN7488403
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant RABV G (Mazorelvimab Biosimilar) antibody (ABIN7488403)
Target
RABV G (Mazorelvimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Lyssavirus rabies (RABV)
Host
All hosts for RABV G (Mazorelvimab Biosimilar) antibodies
Humanized
Clonality
All clonalities for RABV G (Mazorelvimab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for RABV G (Mazorelvimab Biosimilar) antibodies
This RABV G (Mazorelvimab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
Product Details anti-RABV G (Mazorelvimab Biosimilar) Antibody
(hide)
Expression System
Mammalian cells
Purpose
Mazorelvimab Biosimilar - Anti-G Glycoprotein mAb - Research Grade
Characteristics
IgG1, kappa
Purification
Recombinant antibody expressed in mammalien cells and purified.
Isotype
IgG1, kappa
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4.
Handling Advice
Avoid repeated freeze-thaw cycles
Storage
4 °C,-20 °C,-80 °C
Storage Comment
4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles
Expiry Date
12 months
Target Details for RABV G (Mazorelvimab Biosimilar)
(hide)
Target
RABV G (Mazorelvimab Biosimilar)
Alternative Name
Mazorelvimab Biosimilar
Target Type
Biosimilar
Background
Anti-G, Anti-Glycoprotein, CTB 012, CTB-012, CTB012, SYN023
UniProt
O92284 , P08667
CAS-No
CAS: 2419087-89-9
Recently viewed
(hide)
Chat with us , powered by LiveChat